Alviggi C, Clarizia R, Pettersson K, Mollo A, Humaidan P, Strina I, Coppola M, Ranieri A, D’Uva M, De Placido G. Suboptimal response to GnRHa long protocol is associated with a common LH polymorphism. Reprod Biomed Online. 2011;22(Suppl 1):S67-72.
Article
PubMed
Google Scholar
Couzinet B, Lestrat N, Brailly S, Forest M, Schaison G. Stimulation of ovarian follicular maturation with pure follicle-stimulating hormone in women with gonadotropin deficiency. J Clin Endocrinol Metab. 1988;66(3):552–6.
Article
CAS
PubMed
Google Scholar
Kaufmann R, Dunn R, Vaughn T, Hughes G, O’Brien F, Hemsey G, Thomson B, O’Dea LS. Recombinant human luteinizing hormone, lutropin alfa, for the induction of follicular development and pregnancy in profoundly gonadotrophin-deficient women. Clin Endocrinol. 2007;67(4):563–9.
CAS
Google Scholar
Shoham Z, Smith H, Yeko T, O’Brien F, Hemsey G, O’Dea L. Recombinant LH (lutropin alfa) for the treatment of hypogonadotrophic women with profound LH deficiency: a randomized, double-blind, placebo-controlled, proof-of-efficacy study. Clin Endocrinol. 2008;69(3):471–8.
Article
CAS
Google Scholar
Arvis P, Massin N, Lehert P. Effect of recombinant LH supplementation on cumulative live birth rate compared with FSH alone in poor ovarian responders: a large, real-world study. Reprod Biomed Online. 2021;42(3):546–54.
Article
CAS
PubMed
Google Scholar
Marchiani S, Tamburrino L, Benini F, Pallecchi M, Bignozzi C, Conforti A, Alviggi C, Vignozzi L, Danza G, Pellegrini S, et al. LH supplementation of ovarian stimulation protocols influences follicular fluid steroid composition contributing to the improvement of ovarian response in poor responder women. Sci Rep. 2020;10(1):12907.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ar G. Cheemakurthi R, Prathigudupu K, Balabomma KL, Kalagara M, Thota S, Kota M: Role of Lh polymorphisms and r-hLh supplementation in GnRh agonist treated ART cycles: A cross sectional study. Eur J Obstet Gynecol Reprod Biol. 2018;222:119–25.
Article
CAS
Google Scholar
Ren J, Sha A, Han D, Li P, Geng J, Ma C. Does prolonged pituitary down-regulation with gonadotropin-releasing hormone agonist improve the live-birth rate in in vitro fertilization treatment? Fertil Steril. 2014;102(1):75–81.
Article
CAS
PubMed
Google Scholar
Li F, Ye T, Kong H, Li J, Hu L, Jin H, Su Y, Li G. Efficacies of different ovarian hyperstimulation protocols in poor ovarian responders classified by the POSEIDON criteria. Aging. 2020;12(10):9354–64.
Article
PubMed
PubMed Central
Google Scholar
FJ Broekmans RE Bernardus G Berkhout J Schoemaker 1992 Pituitary and ovarian suppression after early follicular and mid-luteal administration of a LHRH agonist in a depot formulation: decapeptyl CR Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 6 3 153 161
Borm G, Mannaerts B: Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial. The European Orgalutran Study Group. Human reproduction 2000, 15(7):1490–1498.
Felberbaum RE, Albano C, Ludwig M, Riethmuller-Winzen H, Grigat M, Devroey P, Diedrich K. Ovarian stimulation for assisted reproduction with HMG and concomitant midcycle administration of the GnRH antagonist cetrorelix according to the multiple dose protocol: a prospective uncontrolled phase III study. Hum Reprod. 2000;15(5):1015–20.
Article
CAS
PubMed
Google Scholar
Hill MJ, Levens ED, Levy G, Ryan ME, Csokmay JM, DeCherney AH, Whitcomb BW: The use of recombinant luteinizing hormone in patients undergoing assisted reproductive techniques with advanced reproductive age: a systematic review and meta-analysis. Fertility and sterility 2012, 97(5):1108–1114 e1101.
Lehert P, Kolibianakis EM, Venetis CA, Schertz J, Saunders H, Arriagada P, Copt S, Tarlatzis B. Recombinant human follicle-stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted reproductive technology: systematic review and meta-analysis. Reproductive biology and endocrinology : RB&E. 2014;12:17.
Article
CAS
Google Scholar
Santi D, Casarini L, Alviggi C, Simoni M. Efficacy of Follicle-Stimulating Hormone (FSH) Alone, FSH + Luteinizing Hormone, Human Menopausal Gonadotropin or FSH + Human Chorionic Gonadotropin on Assisted Reproductive Technology Outcomes in the “Personalized” Medicine Era: A Meta-analysis. Front Endocrinol. 2017;8:114.
Article
Google Scholar
Oliveira JB, Mauri AL, Petersen CG, Martins AM, Cornicelli J, Cavanha M, Pontes A, Baruffi RL, Franco JG Jr. Recombinant luteinizing hormone supplementation to recombinant follicle-stimulation hormone during induced ovarian stimulation in the GnRH-agonist protocol: a meta-analysis. J Assist Reprod Genet. 2007;24(2–3):67–75.
Article
PubMed
Google Scholar
Baruffi RL, Mauri AL, Petersen CG, Felipe V, Martins AM, Cornicelli J, Cavagna M, Oliveira JB, Franco JG Jr. Recombinant LH supplementation to recombinant FSH during induced ovarian stimulation in the GnRH-antagonist protocol: a meta-analysis. Reprod Biomed Online. 2007;14(1):14–25.
Article
CAS
PubMed
Google Scholar
Kolibianakis EM, Kalogeropoulou L, Griesinger G, Papanikolaou EG, Papadimas J, Bontis J, Tarlatzis BC. Among patients treated with FSH and GnRH analogues for in vitro fertilization, is the addition of recombinant LH associated with the probability of live birth? A systematic review and meta-analysis. Hum Reprod Update. 2007;13(5):445–52.
Article
CAS
PubMed
Google Scholar
Mochtar MH, Van der V, Ziech M, van Wely M: Recombinant Luteinizing Hormone (rLH) for controlled ovarian hyperstimulation in assisted reproductive cycles. The Cochrane database of systematic reviews 2007(2):CD005070.
Xiong Y, Bu Z, Dai W, Zhang M, Bao X, Sun Y. Recombinant luteinizing hormone supplementation in women undergoing in vitro fertilization/ intracytoplasmic sperm injection with gonadotropin releasing hormone antagonist protocol: a systematic review and meta-analysis. Reproductive biology and endocrinology : RB&E. 2014;12:109.
Article
CAS
Google Scholar
Alviggi C, Conforti A, Esteves SC, Andersen CY, Bosch E, Buhler K, Ferraretti AP, De Placido G, Mollo A, Fischer R, et al. Recombinant luteinizing hormone supplementation in assisted reproductive technology: a systematic review. Fertil Steril. 2018;109(4):644–64.
Article
CAS
PubMed
Google Scholar
Buhler KF, Fischer R. Recombinant human LH supplementation versus supplementation with urinary hCG-based LH activity during controlled ovarian stimulation in the long GnRH-agonist protocol: a matched case-control study. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology. 2012;28(5):345–50.
Article
CAS
Google Scholar
Canosa S, Carosso AR, Mercaldo N, Ruffa A, Evangelista F, Bongioanni F, Benedetto C, Revelli A, Gennarelli G: Effect of rLH Supplementation during Controlled Ovarian Stimulation for IVF: Evidence from a Retrospective Analysis of 1470 Poor/Suboptimal/Normal Responders Receiving Either rFSH plus rLH or rFSH Alone. Journal of clinical medicine 2022, 11(6).
Gardner DK, Lane M, Stevens J, Schlenker T, Schoolcraft WB: Reprint of: Blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transfer. Fertility and sterility 2019, 112(4 Suppl1):e81-e84.
Balasch J, Fabregues F. Is luteinizing hormone needed for optimal ovulation induction? Curr Opin Obstet Gynecol. 2002;14(3):265–74.
Article
PubMed
Google Scholar
Balasch J, Creus M, Fabregues F, Civico S, Carmona F, Puerto B, Casamitjana R, Vanrell JA. The effect of exogenous luteinizing hormone (LH) on oocyte viability: evidence from a comparative study using recombinant human follicle-stimulating hormone (FSH) alone or in combination with recombinant LH for ovarian stimulation in pituitary-suppressed women undergoing assisted reproduction. J Assist Reprod Genet. 2001;18(5):250–6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Alviggi C, Clarizia R, Mollo A, Ranieri A, De Placido G. Who needs LH in ovarian stimulation? Reprod Biomed Online. 2011;22(Suppl 1):S33-41.
Article
PubMed
Google Scholar
Porter RN, Smith W, Craft IL, Abdulwahid NA, Jacobs HS. Induction of ovulation for in-vitro fertilisation using buserelin and gonadotropins. Lancet. 1984;2(8414):1284–5.
Article
CAS
PubMed
Google Scholar
Borini A, Dal Prato L. Tailoring FSH and LH administration to individual patients. Reprod Biomed Online. 2005;11(3):283–93.
Article
CAS
PubMed
Google Scholar
Lei J, Bei X. Role of LH in the follicular development and LH pretreatment in the early follicular phase. J Reprod Med. 2014;23(12):940–3.
Google Scholar
Choi J, Smitz J. Luteinizing hormone and human chorionic gonadotropin: origins of difference. Mol Cell Endocrinol. 2014;383(1–2):203–13.
Article
CAS
PubMed
Google Scholar
Pezzuto A, Ferrari B, Coppola F, Nardelli GB. LH supplementation in down-regulated women undergoing assisted reproduction with baseline low serum LH levels. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology. 2010;26(2):118–24.
Article
CAS
Google Scholar
Songjun L, Xiu S, Ruiqiong Z, Cailian Y, Hong Z, Weifen D, Haijie G. Early supplementation of rLH improves outcome of IVF/ET in modified ultra-long protocal. J Reprod Med. 2016;25(11):977–82.
Google Scholar
Xiumin J, Yusheng L, Shengxia Z, Xianhong T. Effect of serum LH variation on clinical outcome in women undergoing IVF/ICSI-ET with standard protocols. Chinese Journal of Reproduction and Contraception. 2015;35(1):30–6.
Google Scholar
Lifeng T, Qiongfang W, Jun T, Qiong S, You L, Dingfei X. Clinical outcome of r-LH supplementation in patients with lower serum LH level in the long down-regulation protocal of early follicular phase. J Reprod Med. 2018;27(4):310–5.
Google Scholar
Fleming R, Lloyd F, Herbert M, Fenwick J, Griffiths T, Murdoch A. Effects of profound suppression of luteinizing hormone during ovarian stimulation on follicular activity, oocyte and embryo function in cycles stimulated with purified follicle stimulating hormone. Hum Reprod. 1998;13(7):1788–92.
Article
CAS
PubMed
Google Scholar
Westergaard LG, Laursen SB, Andersen CY. Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction. Hum Reprod. 2000;15(5):1003–8.
Article
CAS
PubMed
Google Scholar
Jeppesen JV, Kristensen SG, Nielsen ME, Humaidan P, Dal Canto M, Fadini R, Schmidt KT, Ernst E, Yding Andersen C. LH-receptor gene expression in human granulosa and cumulus cells from antral and preovulatory follicles. J Clin Endocrinol Metab. 2012;97(8):E1524-1531.
Article
CAS
PubMed
PubMed Central
Google Scholar
Harper JC, de Die-Smulders C, Goossens V, Harton G, Moutou C, Repping S, Scriven PN, SenGupta S, Traeger-Synodinos J, Van Rij MC, et al. ESHRE PGD consortium data collection VII: cycles from January to December 2004 with pregnancy follow-up to October 2005. Hum Reprod. 2008;23(4):741–55.
Article
CAS
PubMed
Google Scholar
Drakakis P, Loutradis D, Kallianidis K, Liapi A, Milingos S, Makrigiannakis A, Dionyssiou-Asteriou A, Michalas S. Small doses of LH activity are needed early in ovarian stimulation for better quality oocytes in IVF-ET. Eur J Obstet Gynecol Reprod Biol. 2005;121(1):77–80.
Article
CAS
PubMed
Google Scholar
Shoham Z. The clinical therapeutic window for luteinizing hormone in controlled ovarian stimulation. Fertil Steril. 2002;77(6):1170–7.
Article
PubMed
Google Scholar
Lahoud R, Al-Jefout M, Tyler J, Ryan J, Driscoll G. A relative reduction in mid-follicular LH concentrations during GnRH agonist IVF/ICSI cycles leads to lower live birth rates. Hum Reprod. 2006;21(10):2645–9.
Article
CAS
PubMed
Google Scholar
Humaidan P, Bungum M, Bungum L, Yding Andersen C. Effects of recombinant LH supplementation in women undergoing assisted reproduction with GnRH agonist down-regulation and stimulation with recombinant FSH: an opening study. Reprod Biomed Online. 2004;8(6):635–43.
Article
CAS
PubMed
Google Scholar
Marrs R, Meldrum D, Muasher S, Schoolcraft W, Werlin L, Kelly E. Randomized trial to compare the effect of recombinant human FSH (follitropin alfa) with or without recombinant human LH in women undergoing assisted reproduction treatment. Reprod Biomed Online. 2004;8(2):175–82.
Article
CAS
PubMed
Google Scholar
Matorras R, Prieto B, Exposito A, Mendoza R, Crisol L, Herranz P, Burgues S. Mid-follicular LH supplementation in women aged 35–39 years undergoing ICSI cycles: a randomized controlled study. Reprod Biomed Online. 2009;19(6):879–87.
Article
CAS
PubMed
Google Scholar
Bosch E, Labarta E, Crespo J, Simon C, Remohi J, Pellicer A. Impact of luteinizing hormone administration on gonadotropin-releasing hormone antagonist cycles: an age-adjusted analysis. Fertil Steril. 2011;95(3):1031–6.
Article
CAS
PubMed
Google Scholar
Vuong TN, Phung HT, Ho MT. Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged >/=35 years: a randomized controlled trial. Hum Reprod. 2015;30(5):1188–95.
Article
CAS
PubMed
Google Scholar
Younis JS, Izhaki I, Ben-Ami M. The effect of LH supplementation to the GnRH antagonist protocol in advanced reproductive ageing women: a prospective randomized controlled study. Clin Endocrinol. 2016;84(1):99–106.
Article
CAS
Google Scholar
Fatemi HM, Van Vaerenbergh I. Significance of premature progesterone rise in IVF. Curr Opin Obstet Gynecol. 2015;27(3):242–8.
Article
PubMed
Google Scholar
Ferraretti AP, Gianaroli L, Motrenko T, Feliciani E, Tabanelli C, Magli MC. LH pretreatment as a novel strategy for poor responders. Biomed Res Int. 2014;2014: 926172.
Article
PubMed
PubMed Central
CAS
Google Scholar
Humaidan P, Chin W, Rogoff D, D’Hooghe T, Longobardi S, Hubbard J, Schertz J. Efficacy and safety of follitropin alfa/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders. Hum Reprod. 2017;32(7):1537–8.
Article
CAS
PubMed
PubMed Central
Google Scholar